Tianjin Lisheng Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000NJ9
CNY
23.83
0.4 (1.71%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
384.73
275.77
355.66
364.19
312.38
274.15
373.03
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
384.73
275.77
355.66
364.19
312.38
274.15
373.03
Raw Material Cost
204.15
132.32
149.63
161.42
149.09
139.28
160.91
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.34
0.63
0.92
0.36
0.96
0.00
0.80
Selling and Distribution Expenses
132.92
85.78
146.18
138.83
124.41
93.61
145.42
Other Expenses
2.37
2.88
2.67
2.88
3.11
3.86
2.68
Total Expenditure (Excl Depreciation)
361.09
247.55
323.42
329.37
305.56
271.45
333.89
Operating Profit (PBDIT) excl Other Income
23.599999999999998
28.2
32.2
34.8
6.800000000000001
2.7
39.1
Other Income
10.16
6.52
320.41
31.89
97.29
8.50
22.88
Operating Profit (PBDIT)
43.05
49.42
356.10
86.60
104.34
31.79
81.80
Interest
0.34
0.63
0.92
0.36
0.96
0.00
0.80
Exceptional Items
-0.29
2.60
-1.20
1.01
1.59
0.19
1.12
Gross Profit (PBDT)
180.59
143.45
206.03
202.76
163.30
134.87
212.12
Depreciation
19.82
19.82
19.89
19.89
20.82
20.82
19.78
Profit Before Tax
22.59
31.57
334.09
67.36
84.15
11.16
62.34
Tax
-25.85
2.62
45.32
10.79
-3.71
14.33
10.45
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
45.54
27.82
287.65
55.28
15.28
66.90
43.20
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
45.54
27.82
287.65
55.28
15.28
66.90
43.20
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
2.90
1.13
1.12
1.30
2.35
0.16
2.21
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
48.44
28.95
288.77
56.57
17.63
67.05
45.40
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
4,628.06
4,969.56
5,005.17
4,797.88
4,769.92
4,970.58
4,901.70
Earnings per share (EPS)
0.18
0.11
1.12
0.22
0.06
0.26
0.17
Diluted Earnings per share
0.18
0.11
1.12
0.22
0.06
0.26
0.17
Operating Profit Margin (Excl OI)
3.4%
8.37%
4.44%
9.56%
-4.41%
0.9%
10.49%
Gross Profit Margin
11.02%
18.63%
99.53%
23.96%
33.6%
11.66%
22.01%
PAT Margin
11.84%
10.09%
80.88%
15.18%
4.89%
24.4%
11.58%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is 39.49% vs -22.46% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is 67.47% vs -89.99% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is -23.31% vs 20.17% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Dec 2025 is -50.00% vs -33.33% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

Compare Quarterly Results Of Tianjin Lisheng Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
384.73
0
384.73
Other Operating Income
0.00
0.00
0.00
Total Operating income
384.73
0
384.73
Raw Material Cost
204.15
0
204.15
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.34
0
0.34
Selling and Distribution Expenses
132.92
0
132.92
Other Expenses
2.37
0.00
2.37
Total Expenditure (Excl Depreciation)
361.09
0
361.09
Operating Profit (PBDIT) excl Other Income
23.64
0.00
23.64
Other Income
10.16
0
10.16
Operating Profit (PBDIT)
43.05
0
43.05
Interest
0.34
0
0.34
Exceptional Items
-0.29
0
-0.29
Gross Profit (PBDT)
180.59
0
180.59
Depreciation
19.82
0
19.82
Profit Before Tax
22.59
0
22.59
Tax
-25.85
0
-25.85
Provisions and contingencies
0
0
0.00
Profit After Tax
45.54
0
45.54
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
45.54
0
45.54
Share in Profit of Associates
0
0
0.00
Minority Interest
2.90
0
2.90
Other related items
0.00
0.00
0.00
Consolidated Net Profit
48.44
0
48.44
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
4,628.06
0
4,628.06
Earnings per share (EPS)
0.18
0
0.18
Diluted Earnings per share
0.18
0
0.18
Operating Profit Margin (Excl OI)
3.40%
0%
0.00
3.40%
Gross Profit Margin
11.02%
0%
0.00
11.02%
PAT Margin
11.84%
0%
0.00
11.84%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 38.47 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 39.49% vs -22.46% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 23.14% vs 29.36% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 4.84 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 67.47% vs -89.99% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 175.00% vs -8.33% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.29 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -23.31% vs 20.17% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 370.00% vs 7,100.00% in Dec 2024

Quarterly - Interest
Interest 0.03 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -50.00% vs -33.33% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -70.00% vs 233.33% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 3.40%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024